Despite their value, pediatric DUS remain underused in clinical and regulatory decision-making. DUS should be systematically integrated into the development and revision of clinical guidelines on medication use and used routinely to evaluate the effects of major regulatory initiatives. Establishing near - real-time monitoring systems and extending DUS to inpatient settings would further strengthen their ability to impact clinical practice and support safer and more evidence-based prescribing for children and adolescents.
Building similarity graph...
Analyzing shared references across papers
Loading...
Helene Kildegaard
Anton Pottegård
Expert Opinion on Drug Safety
University of Southern Denmark
Copenhagen University Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Kildegaard et al. (Mon,) studied this question.
www.synapsesocial.com/papers/69ccb62016edfba7beb87dba — DOI: https://doi.org/10.1080/14740338.2026.2652916